Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers

Area of Science:

• Oncology
• Biochemistry
• Plasma Medicine

Background:

• Cancer cells exhibit an imbalanced antioxidant system, making them susceptible to redox fluctuations.
• Cell surface receptors detect stress and initiate intracellular signaling, influencing cancer progression.
• Targeting cell receptors is a key strategy in cancer therapy, but mutations can lead to drug resistance.

Purpose of the Study:

• To investigate the relationship between cell receptor categories, cancer hallmarks, and responses to redox perturbations.
• To explore cold atmospheric plasma (CAP) as a therapeutic modality for aggressive cancers by targeting cell receptors.
• To assess CAP's potential in overcoming drug resistance through dynamic receptor targeting.

Main Methods:

• Focused case studies analyzing cell receptor categories and cancer hallmarks.
• Examination of redox perturbations and their impact on cancer cells.
• Evaluation of cold atmospheric plasma (CAP) as a therapeutic intervention.

Main Results:

• A clear link was established between cell receptor types and cancer hallmarks influenced by redox changes.
• Cold atmospheric plasma (CAP) demonstrated potential as a selective anti-cancer therapeutic.
• CAP showed promise in modulating redox balance and targeting diverse cell receptors.

Conclusions:

• Understanding the interplay between cell receptors and redox status is crucial for developing novel cancer therapies.
• Cold atmospheric plasma (CAP) presents a promising, selective therapeutic approach for aggressive cancers, potentially minimizing drug resistance.
• Targeting cell receptors with redox-modulating agents like CAP offers new clinical avenues against challenging cancers.